Niagara Falls, NY, Aug. 26, 2024 (GLOBE NEWSWIRE) -- Positron Corporation (“Positron” or the “Company”) (OTC: POSC), a leading molecular imaging medical device company offering PET and PET-CT (Positron Emission Tomography/Computed Tomography) imaging systems and clinical services, is pleased to announce the sale of Positron’s NeuSight PET-CT 64 slice scanner to a recognized leader in preventive, invasive and interventional cardiovascular services.
The NeuSight PET-CT was designed to revolutionize cardiac PET imaging, offering unparalleled value, empowering practices with cutting-edge technology at an unmatched price. The NeuSight PET-CT scanner is a highly acclaimed, top performing scanner, with 500 installations throughout the world. An important feature is the systems design for patient comfort with a spacious 72cm gantry and high-sensitivity acquisition technology ensures safety with minimal radiation exposure for patients and technicians. The NeuSight PET-CT scanner has the smallest footprint and lightest weight of any PET-CT 64 slice system in the industry.
The NeuSight PET-CT scanner is an innovative, inexpensive PET-CT system making it ideal for both cardiology and oncology clinical studies having superior data acquisition, with identification technology for improved scanning speed and accuracy. The NeuSight PET-CT system provides anatomic and functional imaging with qualified designs and technology, serving multiple molecular imaging functions for heart, tumor, and brain imaging studies.
Ad Statistics
Times Displayed: 72739
Times Visited: 5303 MIT labs, experts in Multi-Vendor component level repair of: MRI Coils, RF amplifiers, Gradient Amplifiers Contrast Media Injectors. System repairs, sub-assembly repairs, component level repairs, refurbish/calibrate. info@mitlabsusa.com/+1 (305) 470-8013
Adel Abdullah, President of Positron stated, “We are thrilled to have our first NeuSight PET-CT with such an esteemed cardiovascular physician and practice, dedicated to delivering expert cardiac care and we look forward to supporting their needs as they expand their practice in the future.”
Mr. Abdullah continued, “Since we introduced our NeuSight PET-CT in late July, we have been very pleased with the enthusiasm from many nuclear cardiologists who are interested in our PET-CT technology and its unmatched price point in the imaging market. The NeuSight PET-CT is the perfect solution for advanced nuclear cardiac studies, and we look forward to continuing to offer this unique combination of technology, services and value to practices and hospitals for many years to come.”
About Positron Corporation
Positron Corporation is a medical technology company that co-develops, manufactures, and sells state-of-the-art PET and PET-CT imaging systems and clinical services to nuclear medicine healthcare providers throughout North America.
